Biotech SF
San Francisco Bay Area biotech stories.
Wednesday, May 23, 2012
XDx links with LabCorp in lupus licensing deal
XDx Inc
will work with
Laboratory Corporation of America Holdings
to develop a test used on lupus patients
.
The test will attempt to predict when the active phase of the autoimmune disease is likely to "flare up," thus making treatment more precise and less harmful to patients.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment